サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1271078

胸部大動脈ステントグラフトのパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業（2023年版）

Thoracic Aortic Stent Grafts Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
出版日: | 発行: GlobalData | ページ情報: 英文 77 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
胸部大動脈ステントグラフトのパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業（2023年版）
出版日: 2023年04月19日
発行: GlobalData
ページ情報: 英文 77 Pages
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、胸部大動脈ステントグラフトのパイプライン製品について調査分析し、各開発段階における製品の比較分析や、進行中の臨床試験についての情報を含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

  • 胸部大動脈ステントグラフト - パイプライン製品：開発段階別
  • 胸部大動脈ステントグラフト - パイプライン製品：地域別
  • 胸部大動脈ステントグラフト - パイプライン製品：規制経路別
  • 胸部大動脈ステントグラフト - パイプライン製品：推定承認日別
  • 胸部大動脈ステントグラフト - 進行中の臨床試験

第4章 胸部大動脈ステントグラフト - 開発中のパイプライン製品：企業別

  • 胸部大動脈ステントグラフト企業 - パイプライン製品：開発段階別
  • 胸部大動脈ステントグラフト - パイプライン製品：開発段階別

第5章 胸部大動脈ステントグラフトの企業と製品の概要

  • APT Medical Inc：企業の概要
    • APT Medical Inc：パイプライン製品と進行中の臨床試験の概要
  • Artivion Inc：企業の概要
    • Artivion Inc：パイプライン製品と進行中の臨床試験の概要
  • Beijing Tianzhu Ruichang Medical Technology Co Ltd：企業の概要
    • Beijing Tianzhu Ruichang Medical Technology Co Ltd：パイプライン製品と進行中の臨床試験の概要
  • EndoSpan Ltd：企業の概要
    • EndoSpan Ltd：パイプライン製品と進行中の臨床試験の概要
  • Evasc Medical Systems Corp：企業の概要
    • Evasc Medical Systems Corp：パイプライン製品と進行中の臨床試験の概要
  • Hangzhou Endonom Medtech Co Ltd：企業の概要
    • Hangzhou Endonom Medtech Co Ltd：パイプライン製品と進行中の臨床試験の概要
  • JOTEC GmbH：企業の概要
    • JOTEC GmbH：パイプライン製品と進行中の臨床試験の概要
  • Lombard Medical Technologies Inc.：企業の概要
    • Lombard Medical Technologies Inc.：パイプライン製品と進行中の臨床試験の概要
  • Lundquist：企業の概要
    • Lundquist：パイプライン製品と進行中の臨床試験の概要
  • Medtronic Plc：企業の概要
    • Medtronic Plc：パイプライン製品と進行中の臨床試験の概要
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology：企業の概要
    • Sree Chitra Tirunal Institute for Medical Sciences & Technology：パイプライン製品と進行中の臨床試験の概要
  • St. Jude Medical LLC：企業の概要
    • St. Jude Medical LLC：パイプライン製品と進行中の臨床試験の概要
  • Terumo Aortic：企業の概要
    • Terumo Aortic：パイプライン製品と進行中の臨床試験の概要
  • TriVascular Inc：企業の概要
    • TriVascular Inc：パイプライン製品と進行中の臨床試験の概要
  • Zylox-Tonbridge Medical Technology Co Ltd：企業の概要
    • Zylox-Tonbridge Medical Technology Co Ltd：パイプライン製品と進行中の臨床試験の概要

第6章 胸部大動脈ステントグラフト - 最近の発展

第7章 付録

目次
Product Code: GDME1520EPD

Abstract

GlobalData's Medical Devices sector report, "Thoracic Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Thoracic Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Thoracic Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Thoracic Aortic Stent Grafts Overview

3 Products under Development

  • 3.1 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development
  • 3.2 Thoracic Aortic Stent Grafts - Pipeline Products by Territory
  • 3.3 Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • 3.4 Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • 3.5 Thoracic Aortic Stent Grafts - Ongoing Clinical Trials

4 Thoracic Aortic Stent Grafts - Pipeline Products under Development by Companies

  • 4.1 Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • 4.2 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development

5 Thoracic Aortic Stent Grafts Companies and Product Overview

  • 5.1 APT Medical Inc Company Overview
    • 5.1.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Artivion Inc Company Overview
    • 5.2.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Beijing Tianzhu Ruichang Medical Technology Co Ltd Company Overview
    • 5.3.1 Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 EndoSpan Ltd Company Overview
    • 5.4.1 EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Evasc Medical Systems Corp Company Overview
    • 5.5.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Hangzhou Endonom Medtech Co Ltd Company Overview
    • 5.6.1 Hangzhou Endonom Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 JOTEC GmbH Company Overview
    • 5.7.1 JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Lombard Medical Technologies Inc. Company Overview
    • 5.8.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Lundquist Company Overview
    • 5.9.1 Lundquist Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Medtronic Plc Company Overview
    • 5.10.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.11.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 St. Jude Medical LLC Company Overview
    • 5.12.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Terumo Aortic Company Overview
    • 5.13.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 TriVascular Inc Company Overview
    • 5.14.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
    • 5.15.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Thoracic Aortic Stent Grafts- Recent Developments

  • 6.1 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
  • 6.2 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
  • 6.3 Feb 23, 2023: LeMaitre Q4 2022 Financial Results
  • 6.4 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
  • 6.5 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president
  • 6.6 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
  • 6.7 Nov 23, 2022: Medtronic Reports Quarterly Earnings
  • 6.8 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
  • 6.9 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
  • 6.10 Oct 17, 2022: LeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022
  • 6.11 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022
  • 6.12 Sep 07, 2022: Medtronic to appear at September investor conferences
  • 6.13 Aug 31, 2022: LeMaitre to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
  • 6.14 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
  • 6.15 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
  • 6.16 Jul 28, 2022: LeMaitre Q2 2022 Financial Results
  • 6.17 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022
  • 6.18 Jul 18, 2022: LeMaitre Will Announce Second Quarter 2022 Earnings Results July 28, 2022
  • 6.19 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022
  • 6.20 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
  • 6.21 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
  • 6.22 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
  • 6.23 Apr 28, 2022: LeMaitre Q1 2022 Financial Results
  • 6.24 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022
  • 6.25 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer